Candriam S.C.A. Shockwave Medical, Inc. Transaction History

Candriam S.C.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$194.33 - $283.97 $194,330 - $283,970	1,000 Added 11.11%	10,000 $1.99 Million
Q2 2023 Aug 08, 2023	SELL	$223.05 - $302.68 $1.66 Million - $2.25 Million	-7,441 Reduced 45.26%	9,000 $2.57 Million
Q1 2023 May 12, 2023	BUY	$175.41 - $217.92 $461,328 - $573,129	2,630 Added 19.04%	16,441 $3.56 Million
Q4 2022 Feb 13, 2023	BUY	$204.38 - $296.82 $513,606 - $745,908	2,513 Added 22.24%	13,811 $2.84 Million
Q3 2022 Nov 10, 2022	SELL	$195.21 - $310.53 $2.36 Million - $3.76 Million	-12,102 Reduced 51.72%	11,298 $3.14 Million
Q2 2022 Aug 03, 2022	BUY	$115.91 - $214.48 $579,550 - $1.07 Million	5,000 Added 27.17%	23,400 $4.47 Million
Q1 2022 May 13, 2022	BUY	$127.96 - $207.36 $511,840 - $829,440	4,000 Added 27.78%	18,400 $3.82 Million
Q4 2021 Feb 10, 2022	BUY	$165.13 - $241.83 $2.38 Million - $3.48 Million	14,400 New	14,400 $2.57 Million

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.